Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase.
about
Protease inhibition as new therapeutic strategy for GI diseasesInflammation in irritable bowel syndrome: Myth or new treatment target?The multifaceted mast cell in inflammatory bowel diseaseEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsUrine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model.Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsTryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome.The Role of Mast Cells in Irritable Bowel Syndrome.Intestinal barrier function in health and gastrointestinal disease.Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome.Intestinal barrier: A gentlemen's agreement between microbiota and immunity.Pathophysiological roles of proteases in gastrointestinal disease.Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.Tryptase compromises corneal epithelial barrier function.Regulation of intestinal permeability: The role of proteasesMucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndromePAR-2-mediated control of barrier function and motility differs between early and late phases of postinfectious gut dysfunction in the rat.Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study.Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
P2860
Q26747722-736C52F9-A782-4CD7-BD26-1AE21C293024Q26768545-3155AC28-16F6-48D2-A4B3-51AB91DA1EE7Q27026764-40E6259F-BFBC-4A86-BEBE-6460CE8035C9Q27027602-AE390C1C-E40F-41C6-8FFD-C01AAF052A82Q35562079-49063A82-F438-44A6-8E46-662268139D82Q35610662-CDCAA537-6385-41DD-8847-180EBF7CE196Q35745630-560FD143-4B65-4621-B0B3-05E491D8891DQ36207200-1773E350-6E2D-4253-9B87-87F752021FD4Q36848940-9E4D49D1-E0AA-4405-B434-7D8048D6C7C2Q37578593-CE868FA6-BAD5-432C-BA9C-B0ED48B6AE88Q38009940-135A74DF-D14A-45EA-95CE-058894ADB4CDQ38014502-CE07ECCE-3EB3-4F86-8434-3A86F525667DQ38052154-9BC24EEA-87CB-4479-A5E8-732E7324F164Q38193901-0F286814-3DDD-4BD5-A033-CB3726169264Q38217233-92186737-5511-4366-A05B-E6F7C012B025Q38678675-86FCE9CF-5DFE-4F44-803A-E97F5B27E055Q38988993-B28A4AB0-8EE6-4A0D-8B31-17858A22C2F9Q39101436-1565564A-B05B-4325-BD9C-1A11F5B8F4E9Q39239228-9503E0B5-56B4-4649-BCD8-0FC9D6B6EF0DQ40402334-BA7BDA78-9DAD-42FC-8183-703D4D5BF164Q42517913-D5CA9110-A70D-4360-9EA8-5E8B47F69118Q47746673-99D08D60-B6F0-4F43-9176-7D7727AB3D64Q48248095-4CF3FB9E-3E5D-48A8-B60F-C43511671A03Q48492553-802C48F5-7960-408D-B047-C6DDAF1BCFD4Q53031023-EE0AAB2A-63C1-4E7B-AC90-0CD934A70C46
P2860
Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@en
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@nl
type
label
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@en
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@nl
prefLabel
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@en
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@nl
P2093
P2860
P1476
Subjects with diarrhea-predomi ...... bility responsive to tryptase.
@en
P2093
Byung Ik Kim
Chong I L Sohn
Dong I L Park
Hong Joo Kim
Jae Woong Lee
Jung Ho Park
Jung-Hwan Park
Woo Kyu Jeon
Yong Kyun Cho
P2860
P2888
P304
P356
10.1007/S10620-009-1094-8
P577
2010-01-20T00:00:00Z